A Double Blinded Study to Examine the Effect of Alpha Agonist Ointment on Fecal Incontinence in Patients With Idiopathic Fecal Incontinence

Inclusion Criteria: * Signed written informed consent. * Male or female subjects 18 to 65 years of age. * Fecal incontinence score over 8. * The patient is able to understand the treatment and is willing to comply with the prescribed regimen. Exclusion Criteria: \- Has a clinically significant history or presence of any of the following conditions: * Known allergy to the API. * Porphyria. * Glaucoma. * Pregnancy or lactation. * Active or past history of cardiovascular or cerebrovascular disease including unstable angina, myocardial infarction, transient ischemic attacks/stroke, clinically significant arrhythmia, congestive heart failure, or cardiac valve abnormalities; * Type 1 diabetes mellitus; * Insulin treated type 2 diabetes mellitus. * Renal insufficiency. * Liver insufficiency. * Malignant disease within 5 years of screening; * Has hypertension (sitting blood pressure over 140/90 mmHg at screening) * History of rectal surgery. * History of HIV, hepatitis B, hepatitis. * Has used, in the last four weeks, drugs that may affect blood coagulation, such as Aspirin (at a dose above 250 mg/day), Warfarin, Sintrom, Enoxaparin, Nadroparin, Heparin, Clopidogrel, Ticlopidine. * Use of tricyclic or monoamine-oxidase inhibitors. * Has upon physical examination a rectal deformation or signs of rectal disease such as fissure, bleeding hemorrhoids, fistula., infection or space occupying lesion. * Unable to understand the use instruction for the ointment, as judged by the investigator.